Daily IV Report
Pre-Market IV Report October 2, 2025
Pre-Market IV Report October 2, 2025 The following report is a snapshot of noteworthy changes in stock and option volumes, as well as changes in option implied volatilities. By monitoring this market data, traders can create strategies that capitalize on this often over looked information Options with increasing option implied volatility: VOR BHVN MNMD SNAP […]
Pre-Market IV Report October 2, 2025
The following report is a snapshot of noteworthy changes in stock and option volumes, as well as changes in option implied volatilities. By monitoring this market data, traders can create strategies that capitalize on this often over looked information
Options with increasing option implied volatility: VOR BHVN MNMD SNAP CVNA TEAM ALGN CHTR ETSY FTAI PYPL NET MELI EL CMG SHAK BAX UPS META
Stocks expected to have increasing option volume: QUBT IONX QBTS RGTI GDRX RUN
Pharma option IV, share prices up
AbbVie (ABBV) 30-day option implied volatility is at 27; compared to its 52-week range of 18 to 52. Call put ratio 2.8 calls to 1 put with a focus on November 210 calls.
Bristol-Myers Squibb (BMY) 30-day option implied volatility is at 34; compared to its 52-week range of 20 to 55. Call put ratio 3.9 calls to 1 put with a focus on a spreader of 10K contracts of November 48 and 52.50 calls.
Eli Lilly & Co. (LLY) 30-day option implied volatility is at 43; compared to its 52-week range of 25 to 64. Call put ratio 2.4 calls to 1 put with a focus on a spreader of November 850 calls.
Johnson & Johnson (JNJ) 30-day option implied volatility is at 19; compared to its 52-week range of 13 to 36. Call put ratio 3.5 calls to 1 put with a focus on January 180 and April 185 calls.
Merck (MRK) 30-day option implied volatility is at 33; compared to its 52-week range of 20 to 55. Call put ratio 2.6 calls to 1 put with a focus on October 3 weekly calls.
Pfizer (PFE) 30-day option implied volatility is at 27; compared to its 52-week range of 18 to 50. Call put ratio 5.7 calls to 1 put with a focus on January 30 and June 35 and 37 calls.
Amgen (AMGN) 30-day option implied volatility is at 27; compared to its 52-week range of 19 to 56.
Novo Nordisk (NVO) 30-day option implied volatility is at 60; compared to its 52-week range of 28 to 70. Call put ratio 3.8 calls to 1 put with a focus on a spreader of December 60 and 85 calls.
Gilead Sciences (GILD) 30-day option implied volatility is at 34; compared to its 52-week range of 19 to 49. Call put ratio 2.3 calls to 1 put with a focus on a spreader of October 115 and 118 calls.
AstraZeneca (AZN) 30-day option implied volatility is at 28; compared to its 52-week range of 20 to 46 on active option volume of 36K contracts.
Moderna (MRNA) 30-day option implied volatility is at 77; compared to its 52-week range of 54 to 105. Call put ratio 9.5 calls to 1 put with a focus on October 3 weekly and October 10 weekly 10 calls.
Baxter (BAX) 30-day option implied volatility is at 48; compared to its 52-week range of 22 to 62. Call put ratio 13.9 calls to 1 put with a focus on October 3 weekly 24 calls.
Thermo Fisher Scientific (TMO) 30-day option implied volatility is at 39; compared to its 52-week range of 19 to 58. Call put ratio 10.1 calls to 1 put with a focus on November calls.
Teva Pharma (TEVA) 30-day option implied volatility is at 40; compared to its 52-week range of 29 to 72. Call put ratio 1.2 calls to 1 put.
SPDR S&P Biotech ETF (XBI) 30-day option implied volatility is at 27; compared to its 52-week range of 24 to 62 on active option volume of 120K contracts.
Health Care Select Sect Fd (XLV) 30-day option implied volatility is at 17; compared to its 52-week range of 11 to 38 on active option volume of 84K contracts.
Spdr S&P Pharmaceuticals Etf (XPH) 30-day option implied volatility is at 18; compared to its 52-week range of 14 to 43 as share price up.
Ishares U.S. Pharmaceuticals Etf (IHE) 30-day option implied volatility is at 15; compared to its 52-week range of 13 to 40 as share price up.
Market Vectors Pharmaceutical Etf (PPH) 30-day option implied volatility is at 18; compared to its 52-week range of 12 to 37 as share price up.
iShares Nasdaq Biotechnology (IBB) 30-day option implied volatility is at 22; compared to its 52-week range of 16 to 46 as share price up.
GoodRx Holdings, Inc. (GDRX) 30-day option implied volatility is at 142; compared to its 52-week range of 44 to 143. Call put ratio 124 calls to 1 put amid share rally.
Movers
DraftKings (DKNG) 30-day option implied volatility is at 51; compared to its 52-week range of 34 to 87. Call put ratio 2.9 calls to 1 put on active option volume of 176K contracts.
Flutter Entertainment (FLUT) 30-day option implied volatility is at 37; compared to its 52-week range of 26 to 62. Call put ratio 2.6 calls to 1 put.
Micron Technology (MU) 30-day option implied volatility is at 54; compared to its 52-week range of 37 to 87 on active option volume of 519K contracts as share price up.
NVIDIA (NVDA) 30-day option implied volatility is at 38; compared to its 52-week range of 32 to 75. Call put ratio 1.8 calls to 1 put as share price near record high.
AMD (AMD) 30-day option implied volatility is at 49; compared to its 52-week range of 35 to 87. Call put ratio 3.5 calls to 1 put with a focus on October 3 weekly calls.
Intel (INTC) 30-day option implied volatility is at 73; compared to its 52-week range of 38 to 93. Call put ratio 2.9 calls to 1 put with a focus on a spreader of November 25 puts, November 30 puts and November 45 calls.
Market Vectors Gold Miners ETF (GDX) 30-day option implied volatility is at 39; compared to its 52-week range of 29 to 50. Call put ratio 2.3 calls to 1 put as gold trades $3890.
Global Xftse Argentina 20 Etf (ARGT) 30-day option implied volatility is at 43; compared to its 52-week range of 22 to 55. Call put ratio 1 call to 2.9 puts as share price down.
AES Corp (AES) 30-day option implied volatility is at 41; compared to its 52-week range of 35 to 68. Call put ratio 4.2 calls to 1 put with a focus on October 3 weekly 13, 15 and 16 calls as share price up 16%.
American Bitcoin (ABTC) 30-day option implied volatility is at 159; compared to its 52-week range of 110 to 178. Call put ratio 61 calls to 1 put with a focus on November 5 and 7.5 calls.
Canadian Solar (CSIQ) 30-day option implied volatility is at 75; compared to its 52-week range of 57 to 98. Call put ratio 22 calls to 1 put with a focus on 12K contracts of January 2027 20 calls as share price up 12.9%.
Peloton (PTON) 30-day option implied volatility is at 81; compared to its 52-week range of 58 to 136. Call put ratio 9.6 calls to 1 put with a focus on with a focus on October 9 calls as share price down 6%.
XP Inc. (XP) 30-day option implied volatility is at 39; compared to its 52-week range of 31 to 81. Call put ratio 1 call to 5.8 puts with a focus on a spreader of 14999 contracts of November 15 and 17 puts.
Beyond Meat (BYND) Bynd 30-day option implied volatility is at 257; compared to its 52-week range of 76 to 301. Call put ratio 1 call to 2.6 puts as share price up 23%.
Options with decreasing option implied volatility: WOLF LAC QURE RGTI CIFR SQNS EA KMX NKE ACN COST
Increasing unusual option volume: CTVA GDRX LAC XP TSLY RVPH
Increasing unusual call option volume: CTVA TSLY GDRX LAC TMO LRMR FLY ROIV VIAV
Increasing unusual put option volume: LAC XP IRM FUN UAMY BYND SNDK RZLV SCHD
Popular stocks with increasing volume: PFE MSTR SMCI INTC PLTR MU NKE AMD SOFI ORCL HOOD COIN
Active options: TSLA NVDA PFE AAPL MSTR META SMCI INTC PLTR AMZN MU OPEN NKE MARA AMD PLUG SOFI ORCL HOOD COIN
Global S&P Futures lower in premarket, Nikkei mixed, DAX up 1%, WTI Crude oil recently at $61.80, natural gas down 1%, gold at $3902
